(b)(4).Baxter medical assessment: while we cannot exclude that the implant has caused or contributed to the reported infection/wound healing disorder, multiple risk factors and alternative causes for infection such as: patient, and disease-related risk factors, and contaminated surgical wounds, use of other implants (sutures, staples), intra-operative contamination, diabetes mellitus or other associated pathologies have to be considered.Even if the batch review proves negative and the implant would have been non-contaminated until its surgical handling and application, due to the known characteristic of any implantable collagen (lot and product independent) to potentially augment the inflammatory and infectious response to surgical field contamination, we cannot rule out that the product may have contributed to the reported wound healing disorder complication.The veritas ifu adequately refers to this risk and the measures to be taken.(¿when clinical circumstances require implantation in a site that is contaminated or infected, appropriate local and/or systemic measures should be taken to manage the contamination/infection.¿) a follow-up report will be submitted upon receipt and evaluation of the manufacturer's investigation.
|
(b)(4).Baxter (b)(4) completed the investigation.Sample evaluation and batch review could not be performed as no sample or lot number were provided.No trend was identified.Per synovis, based on the information provided by the customer, the root cause cannot be determined.No further investigation is required as it is not possible to identify that the product was the cause of the issue.This case will be kept on file for trending purposes.
|